Stock Forecast & Price Prediction

Live Stock (BACA) Price
$0.00

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$0.00

P/E Ratio

P/E Ratio not available for BACA

Volume Traded Today

$0

Dividend

Dividends not available for BACA

52 Week High/low

0.00/0.00

Market Cap

$0

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $BACA ๐Ÿ›‘

Before you buy BACA you'll want to see this list of ten stocks that have huge potential. Want to see if BACA made the cut? Enter your email below

BACA Summary

Based on ratings from 0 stock analysts, the stock price is expected to decrease by NAN% in 12 months. This is calculated by using the average 12-month stock price forecast for . The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.

BACA Analyst Ratings

BACA is a stock in which has been forecasted to be worth $ as an average. On the higher end, the forecast price is $ by from and on the lower end BACA is forecasted to be $ by from .

BACA stock forecast by analyst

These are the latest 20 analyst ratings of BACA.

Analyst/Firm

Rating

Price Target

Change

Date

Data Not Found!

BACA Company Information

BACA
(BACA)

When did it IPO

2021

Staff Count

0

Country

Sector/Industry

/

CEO

Market Cap

$0

(BACA) Financial Data

In 2023, BACA generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BACA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year

Revenue From 2023

N/A

0.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.0%
  • Gross profit TTM $0
  • Return on assets TTM 0.0%
  • Return on equity TTM 0.0%
  • Profit Margin 0.0%
  • Book Value Per Share 0.00%
  • Market capitalisation $0
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • Revenue for 2023 N/A
  • EPS this year (TTM) N/A

(BACA) Latest News

News Image

Wed, 25 Sep 2024

Sentiment - NEUTRAL

Source - Newsfile Corp

Summary - Berenson Acquisition Corp. I (NYSE: BACA) will dissolve and liquidate after failing to complete its business combination by September 30, 2024. Liquidation is set for October 16, 2024.

Why It Matters - Berenson Acquisition Corp. I's failure to complete a business combination and subsequent liquidation may lead to losses for investors, affecting market confidence in SPACs and future fundraising efforts.

News Image

Thu, 18 Jul 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Halper Sadeh LLC is investigating Berenson Acquisition Corp. I (BACA) for potential securities law violations related to its merger with Custom Health Inc., which values Custom Health at $185 million pre-money.

Why It Matters - The investigation into Berenson Acquisition Corp. I's merger with Custom Health raises concerns about potential legal issues, which could impact stock performance and shareholder value.

News Image

Mon, 03 Jun 2024

Sentiment - NEUTRAL

Source - Newsfile Corp

Summary - Berenson Acquisition Corp. I disclosed an audit opinion highlighting concerns about its ability to continue as a going concern, as noted in its 2023 annual report filed on May 31, 2024.

Why It Matters - The audit opinion raises concerns about Berenson Acquisition Corp.'s financial stability, signaling potential risks to its operations and impacting investor confidence and stock performance.

News Image

Tue, 23 Apr 2024

Sentiment - NEUTRAL

Source - Newsfile Corp

Summary - Berenson Acquisition Corp. I (NYSE: BACA) received a notice of noncompliance from NYSE for failing to file its 2023 Form 10-K by the deadline. The company aims to regain compliance.

Why It Matters - Noncompliance with NYSE listing standards can lead to delisting, impacting stock liquidity and investor confidence. The company's commitment to regain compliance will be closely monitored.

News Image

Wed, 01 Mar 2023

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Berenson Acquisition Corp. I (NYSE: BACA) will transfer its Class A common stock listing to NYSE American, effective March 13, 2023, while retaining the same ticker symbol.

Why It Matters - The transfer to NYSE American may indicate a shift in the company's market strategy, potentially affecting liquidity, investor perception, and stock volatility.

News Image

Tue, 31 Jan 2023

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Berenson Acquisition Corp. I (NYSE: BACA) canceled its special meeting scheduled for February 7, 2023, and withdrew proposals from its Definitive Proxy Statement filed on November 21, 2022.

Why It Matters - The cancellation of the stockholder meeting and withdrawal of proposals may signal uncertainty or challenges for Berenson Acquisition Corp. I, potentially affecting investor confidence and stock performance.

...

BACA Frequently asked questions

The highest forecasted price for BACA is $ from at .

The lowest forecasted price for BACA is $ from from

The BACA analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.